Cargando…
Evaluation of residual humoral immune response against SARS-CoV-2 by a surrogate virus neutralization test (sVNT) 9 months after BNT162b2 primary vaccination()
The humoral response to SARS-CoV-2 vaccination has shown to be temporary, although may be more prolonged in vaccinated individuals with a history of natural infection. We aimed to study the residual humoral response and the correlation between anti-Receptor Binding Domain (RBD) IgG levels and antibo...
Autores principales: | Pezzati, Laura, Milazzo, Laura, Carrozzo, Giorgia, Kullmann, Cristina, Oreni, Letizia, Beltrami, Martina, Caronni, Stefania, Lai, Alessia, Caberlotto, Livio, Ottomano, Cosimo, Antinori, Spinello, Ridolfo, Anna Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008091/ https://www.ncbi.nlm.nih.gov/pubmed/36914095 http://dx.doi.org/10.1016/j.jiac.2023.03.002 |
Ejemplares similares
-
Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy
por: Milazzo, Laura, et al.
Publicado: (2022) -
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)
por: Meyer, Benjamin, et al.
Publicado: (2020) -
Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
por: Pezzati, Laura, et al.
Publicado: (2021) -
Diagnostic performance between in-house and commercial SARS-CoV-2 serological immunoassays including binding-specific antibody and surrogate virus neutralization test (sVNT)
por: Winichakoon, Poramed, et al.
Publicado: (2023) -
Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay
por: Fogolari, Marta, et al.
Publicado: (2023)